Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | Kumar & CompanyLikely | 2 | ₹3,259.80 |
| 2 | Schedule 3 | MAMMOTH LIFESCIENCES LLPLikely | 1 | ₹16,094.40 |
| 3 | Schedule 4 | CONCEPT BIOMEDICALLikely | 1 | ₹1.4 L |
| 4 | Schedule 5 | MAMMOTH LIFESCIENCES LLPLikely | 1 | ₹34,454 |
| 5 | Schedule 6 | GAGAN ASSOCIATESLikely | 1 | ₹6.0 L |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
30 Jun 2025, 1:00 pmClosed
Cyclophosphamide 1 gm Inj
Actinomycin 0.5 mg Inj
Afatinib 40 mg Tab
Tab Alpelisib 150 Mg
Aprepitant 1 Cap 125 Mg and 2 Cap 80 Mg
Bevacizumab 300 mg Inj
Inj Bleomycin Sulphate oblique Chloride 15 mg
Tab Cabozantinib 40 Mg
Tab Cabozantinib 60 mg
Inj Cabazitaxel 60 mg
Capecitabine 700 Mg plus cyclophosphamide 30 Mg Tab
Inj Carboplatin 150mg
Inj Carboplatin 450mg
Inj Cetuximab 100 mg
Cisplatin 10mg Inj
Cisplatin 50mg Inj
Docetaxel 20mg 0.5ml Vial plus 1.5ml Solvent fo Inj
Inj Docetaxel 80mg per 2ml Vial 6 ml solvent for Inj
Doxorubicin HCl 2mg per ml 5ml Inj
Epirubicin 50 mg Inj vial of 50 mg
Epirubicin HCl 10mg Inj
Etoposide 100mg
5 ml Inj
Everolimus 10 mg Tab
Everolimus 5 mg Tab
Exemestane 25 mg Tab
Inj Fosaprepitant 150 MG
Gemcitabine 1000mg Inj
Inj Gemcitabine 200mg
Inj Irinotecan 40mg
Isosfamide Inj 1g vial with 3 amp of 2 ml each Mesna
Inj nanosomal paclitaxel lipid suspension 100mg
Inj Nanosomal paclitaxel lipid suspension 30 mg
Netupitant 300 mg and Palonosetron 0.5 mg Fixed dose cap
Oxaliplatin 100mg Inj
Paclitaxel 100 mg Inj
Palanosetron 0.25mg Inj
Pemetrexed 100 mg Inj
Pemetrexed 500 mg Powder for Inj
Procarbazine HCl 50mg Cap
Rasburicase 1.5 mg Inj
Sunitinib 12.5 mg Tab
Sunitinib 25 mg Tab
Sunitinib 50mg Tab
Trifluridine and Tipiracil tab 15mg oblique 6.14mg
Tab Trifluride And Tipiracil 20mg oblique 8.19 mg
Inj Vinorelbine 10 mg
Inj Vinorelbine 50 mg
Zoledronic Acid 4 mg powder for Inj
Tab Morphine sulphate 10 mg
Haffos cream Urea and lactic moisture
Capecitabine Dispersible 1000 mg Tab
Inj Irinotecan 100mg
Tab Trametinib 2 mg
inj Brentuximab vedotin 50 mg per ml
Pegylated Liposomal irinotecan 4.3 mg per ml concentrate for dispersion for infusion
APALUTAMIDE 60 MG TAB
Inj Ramucirumab 500 mg per 50 ml vial
Nano particle paclitaxel polymer base 300 mg
7895723
GEM/2025/B/6280859
Two Packet Bid
Inj Ramucirumab 500 mg per 50 ml vial
28 days
Haryana; Panchkula
Item wise evaluation
BOQ
7 documents required · 7 mandatory
3 yrs
₹39 L
₹39 L
50%
Exempted
30 Jun 2025
9 Jun 2025
30 Jun 2025
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | Cyclophosphamide 1 gm Inj | As per uploaded file | 60 | Vial | path2021 | 28 |
| 2 | Actinomycin 0.5 mg Inj | As per uploaded file | 6 | Vial | path2021 | 28 |
| 3 | Afatinib 40 mg Tab | As per uploaded file | 336 | No | path2021 | 28 |
| 4 | Tab Alpelisib 150 Mg | As per uploaded file | 112 | No | path2021 | 28 |
| 5 | Aprepitant 1 Cap 125 Mg and 2 Cap 80 Mg | As per uploaded file | 214 | No | path2021 | 28 |
| 6 | Bevacizumab 300 mg Inj | As per uploaded file | 90 | Vial | path2021 | 28 |
| 7 | Inj Bleomycin Sulphate oblique Chloride 15 mg | As per uploaded file | 30 | Vial | path2021 | 28 |
| 8 | Tab Cabozantinib 40 Mg | As per uploaded file | 180 | No | path2021 | 28 |
| 9 | Tab Cabozantinib 60 mg | As per uploaded file | 180 | No | path2021 | 28 |
| 10 | Inj Cabazitaxel 60 mg | As per uploaded file | 15 | Vial | path2021 | 28 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7895723.pdf
GEM_BID
bbqr_medicine_2025-05-27-18-06-57_2aa618cadf190a4cb99c55225692d633.pdf
BOQ
csv18_2025-05-27-18-06-57_5ca13dab9ee5c600065ca51503c5e486.csv
BOQ
1748350336.pdf
OTHER
1748350366.pdf
OTHER
atc2_9a1abdf0-6c29-4318-8bb81748350393059_hodvascular.pdf
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .